A study published in The Lancet Oncology establishes for the first time that artificial intelligence can process medical images to extract biological and clinical information.
By designing an algorithm and developing it to analyse CT scan images, medical researchers at Gustave Roussy, CentraleSupélec, Inserm, Paris-Sud University and TheraPanacea (spin-off from CentraleSupélec specialising in artificial intelligence in oncology-radiotherapy and precision medicine) have created a so-called radiomic signature. This signature defines the level of lymphocyte infiltration of a tumour and provides a predictive score for the efficacy of immunotherapy in the patient.
In the future, physicians might thus be able to use imaging to identify biological phenomena in a tumour located in any part of the body without having to perform a biopsy.
Up to now, no marker can accurately identify those patients who will respond to anti-PD-1/PD-L1 immunotherapy in a situation where only 15 to 30% of patients do respond to such treatment. It is known that the richer the tumour environment is immunologically (presence of lymphocytes) the greater the chance that immunotherapy will be effective, so the researchers have tried to characterise this environment using imaging and correlate this with the patients’ clinical response. Such is the objective of the radiomic signature designed and validated in the study published in The Lancet Oncology.
In this retrospective study, the radiomic signature was captured, developed and validated in 500 patients with solid tumours (all sites) from four independent cohorts. It was validated genomically, histologically and clinically, making it particularly robust.
Using an approach based on machine learning, the team first taught the algorithm to use relevant information extracted from CT scans of patients participating in the MOSCATO* study , which also held tumor genome data. Thus, based solely on images, the algorithm learned to predict what the genome might have revealed about the tumour immune infiltrate, in particular with respect to the presence of cytotoxic T-lymphocytes (CD8) in the tumour, and it established a radiomic signature.
This signature was tested and validated in other cohorts including that of TCGA (The Cancer Genome Atlas) thus showing that imaging could predict a biological phenomenon, providing an estimation of the degree of immune infiltration of a tumour.
Then, to test the applicability of this signature in a real situation and correlate it to the efficacy of immunotherapy, it was evaluated using CT scans performed before the start of treatment in patients participating in 5 phase I trials of anti-PD-1/PD-L1 immunotherapy. It was found that the patients in whom immunotherapy was effective at 3 and 6 months had higher radiomic scores as did those with better overall survival.
The next clinical study will assess the signature both retrospectively and prospectively, will use larger numbers of patients and will stratify them according to cancer type in order to refine the signature.
This will also employ more sophisticated automatic learning and artificial intelligence algorithms to predict patient response to immunotherapy. To that end, the researchers are intending to integrate data from imaging, molecular biology and tissue analysis. This is the objective of the collaboration between Gustave Roussy, Inserm, Université Paris-Sud, CentraleSupélec and TheraPanacea to identify those patients who are the most likely to respond to treatment, thus improving the efficacy/cost ratio of the treatment.
Learn more: Predicting the response to immunotherapy using artificial intelligence
The Latest on: Artificial intelligence
[google_news title=”” keyword=”artificial intelligence” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial intelligence
- Why I Love Axon's Artificial Intelligence Playon April 27, 2024 at 4:00 am
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
- How Artificial Intelligence Is Changing The Way You Buy Travel Insuranceon April 27, 2024 at 3:52 am
Artificial intelligence is transforming the way you buy travel insurance. Here are the surprising ways it could affect your next vacation.
- 3 Top Artificial Intelligence (AI) Stocks That Billionaires Jim Simons, Ray Dalio, and Israel Englander Are Buyingon April 27, 2024 at 12:05 am
Jim Simons, Ray Dalio, and Israel Englander are some of the most successful investors in history. All three are billionaires, and their respective hedge funds -- Renaissance Technologies, Bridgewater ...
- Growing concern that artificial intelligence could pose new cybersecurity threatson April 26, 2024 at 9:26 pm
As the capabilities of AI systems increase, so too do the risks of attacks on banks, infrastructure and elections, expects say.
- U.S. Government Needs to ‘Get It Right’ on Artificial Intelligenceon April 26, 2024 at 6:59 pm
We can't afford to get this wrong—again,” Shalanda Young, the director of the Office of Management and Budget, tells TIME.
- Pope to take part in G7 summit in June to talk Artificial Intelligenceon April 26, 2024 at 5:00 pm
According to a statement from Italian Prime Minister Giorgia Meloni, the pope will take part in a session of the G7 summit dedicated to artificial intelligence, a subject of mounting concern to this ...
- Artificial Intelligence and the Future of Singapore’s Foreign Workforceon April 26, 2024 at 2:20 pm
Without careful regulations, AI will widen the already significant divide between Singaporean workers and the country’s large population of migrant laborers.
- Pope to bring his call for ethical artificial intelligence to G7 summit in June in southern Italyon April 26, 2024 at 10:26 am
Pope Francis is taking his call for artificial intelligence to be developed and used according to ethical lines to the Group of 7 industrialized nations ...
- Steve Aoki Has No Problem Using Artificial Intelligence To Build Tracks: ‘You Can’t Stop AI… You Just Have To Ride The Wave’on April 26, 2024 at 8:37 am
Steve Aoki talks to Billboard about embracing artificial intelligence in making music and the importance of Asian representation in the biz.
- Artificial Intelligence: Major Cyber Threats for Law Firms in 2024on April 26, 2024 at 6:18 am
Because trust is crucial in a lawyer-client relationship, it is of the utmost importance that law firms maintain the highest standards in data security.
via Bing News